Modulight Bio: Funding, Investors & Team (Sep 2026)
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
Modulight Bio has raised $12.0M across 1 funding round on record, the most recent a Seed of $12.0M announced in Nov 2025.
That round is in line with the $12M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Modulight Bio Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Modulight Bio Funding Rounds
Modulight Bio Founders and Leadership Team
Contact details for the Modulight Bio team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Modulight Bio Funding Compared to Other Biotechnology Startups
Modulight Bio's latest round of $12.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Modulight Bio in Biotechnology and Boston
Companies Similar to Modulight Bio
Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and…
Rion Vet mission is to drive the regenerative medicine revolution.
Nomax Therapeutics develops a healthcare technology platform to provide therapies for neurodegenerative…
Gregor Diagnostics is a molecular diagnostics company developing a screening test technology for prostate…
Gut Brain Axis Therapeutics is a biotechnology company that offers treatment for Autism Spectrum Disorder…
iOrganBio is a pioneering cell production platform.
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
NILO Therapeutics is a biotechnology and therapeutics company.
AccufyDx is a Biotechnology Research firm working to change MRD analysis for early detection.Accufy…
Predicta Biosciences provides molecular diagnostics and immunotherapeutic discovery services for…
Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients.
Reprogenix is a groundbreaking medical technology firm
Modulight Bio Funding FAQs
What does Modulight Bio do?
Modulight Bio develops an optogenetic platform intended for the treatment of neurological disorders.
How much funding has Modulight Bio raised?
Modulight Bio has raised $12.0M across 1 round on record. The most recent is a Seed of $12.0M announced in Nov 2025.
When did Modulight Bio last raise funding?
Modulight Bio's most recent funding round on record is a Seed of $12.0M, announced in Nov 2025.
Where is Modulight Bio headquartered?
Modulight Bio is based in Boston, United States.
How many employees does Modulight Bio have?
Modulight Bio is in the 11-50 employee band.
How does Modulight Bio's funding compare to other Biotechnology startups?
Modulight Bio's latest round of $12.0M is in line with the $12M median round size for Biotechnology companies on FundedIQ across 27 tracked companies over the last two years.
About FundedIQ's Modulight Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Modulight Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.